IRIS
FILIPPINI, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.459
EU - Europa 1.320
AS - Asia 100
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.457
IE - Irlanda 516
UA - Ucraina 252
GB - Regno Unito 172
DE - Germania 154
FI - Finlandia 70
SE - Svezia 67
CN - Cina 61
TR - Turchia 33
IT - Italia 32
GR - Grecia 31
BE - Belgio 20
FR - Francia 3
IN - India 2
IR - Iran 2
BR - Brasile 1
CA - Canada 1
EU - Europa 1
GH - Ghana 1
HK - Hong Kong 1
IL - Israele 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
Totale 2.882
Salva come PNG Salva come JPEG
Città #
Dublin 516
Jacksonville 376
Chandler 277
Princeton 72
Ann Arbor 65
Medford 63
San Mateo 56
New York 53
Boardman 46
Bremen 31
Woodbridge 28
Wilmington 25
Roxbury 21
Brussels 20
Mountain View 19
Cambridge 18
Nanjing 12
Düsseldorf 10
Norwalk 9
Beijing 7
Helsinki 7
Jinan 7
Ashburn 5
Auburn Hills 5
Des Moines 5
Kunming 5
Nanchang 5
Hangzhou 4
Catania 3
Lanzhou 3
Los Angeles 3
Shanghai 3
Washington 3
Angri 2
Aversa 2
Caserta 2
Hebei 2
Jiaxing 2
London 2
Munich 2
Naples 2
Ningbo 2
Shenyang 2
Siena 2
Zhengzhou 2
Atlanta 1
Central 1
Changchun 1
Edinburgh 1
Fairfield 1
Groningen 1
Guangzhou 1
Haikou 1
Houston 1
Manchester 1
Marano Di Napoli 1
Mexico 1
Montreal 1
Napoli 1
New Delhi 1
Padre Paraiso 1
Philadelphia 1
Pune 1
Salisbury 1
San Jose 1
Tel Aviv 1
Torre Del Greco 1
Valletta 1
Venice 1
Zanjan 1
Totale 1.831
Salva come PNG Salva come JPEG
Nome #
Quantitative ultrasound criteria for risk stratification in clinical practice: a comparative assessment 69
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 68
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 66
Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis 61
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 61
Does HIV infection favor the sexual transmission of hepatitis C? 57
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 56
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 55
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 55
Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study 54
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 54
Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. 52
Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation 52
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 51
Helicobacter spp. and liver diseases. 50
Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment 49
Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases 49
Absence of occult HCV infection in HIV-positive patients 49
Can HCV affect the efficacy of anti-HIV treatment? 49
Together … to take care: multidisciplinary management of hepatitis C virus treatment in randomly selected drug users with chronic hepatitis 48
Clinical and virological characteristics associated with severe acute hepatitis B 48
HAV replication in acute hepatitis with typical and atypical clinical course 45
Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen 45
Anti-HCV IgG avidity index in acute hepatitis C. 44
Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis 44
Reply : Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer 43
Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART 43
Virological and Clinical Aspects of HBV-HCV Coinfection in HIV Positive Patients. 43
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 43
Hepatitis viruses and HIV infection in the Naples area 43
Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis 43
Uselessness of liver biopsy in patients with hepatitis C virus chronic infection and persistently normal aminotransferase levels. 43
Aspetti virologici e clinici delle infezioni multiple da virus epatitici: dati preliminari di uno studio multicentrico nazionale. 42
[Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study] 41
16. Drug-Resistent Tubercolosis in HIV-infected Persons: Italy 1999-2000 41
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy 40
HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease 39
HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. 39
HBV superinfection in HCV chronic carriers, viral interaction and clinical course 39
Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology 39
Virologic and clinical expression of reciprocal inhibitory effect of hepatitis B, C, and Delta viruses in patients with chronic hepatitis 39
“Isolated” anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment 39
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. 39
Hepatitis C virus infection among drug addicts in Italy 38
Tubercolosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 37
Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. 37
Interaction between HDV and HBV infection in HBsAg-chronic carriers 37
Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe 37
Does HIV infection favour the sexual transmission of hepatitis C? 37
Impact of occult HBV infection in HIV patients naive for anti-retroviral therapy 37
Absence of occult HCV infection in patients experiencing an immunodepression condition 37
[Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies] 36
[Laboratory diagnosis of HIV infection] 36
Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis 35
The role of H2 antagonists in Perennial Allergic Rhinitis 35
HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course 34
[Epidemiological evaluations of human immunodeficiency virus, herpes simplex virus type 1 and 2 and cytomegalovirus infections in drug addicts] 34
Exposure to HAV infection in patients with chronic liver disease in italy, a multicentre study 33
Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy 33
Adherence to HIV treatment: results from a 1-year follow-up study 32
Hyperendemicity of viral hepatitis in the Neapolitan area: an epidemiological study 30
HPV oral infection. Case report of an HIV-positive Nigerian sex worker 30
HBV Superinfection in HCV Chronic Carriers: A Disease That Is Frequently Severe but Associated with the Eradication of HCV 28
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. 28
Absence of occult HCV infection in HIV-positive patients 27
Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection 27
Multiple hepatitis virus infections in chronic HBsAg carriers in Naples 26
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 25
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 20
Clinical and virological characteristics associated with severe acute hepatitis B 16
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection 15
HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV 15
Clinical management of imported malaria in Italy: Results from a national cross-sectional survey in 2015 11
Totale 2.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 6 6
2019/2020332 67 65 5 0 63 5 65 8 45 2 3 4
2020/2021502 62 1 71 15 85 3 67 61 3 75 43 16
2021/2022431 57 1 3 9 119 3 15 6 20 45 37 116
2022/20231.020 76 7 14 83 114 95 0 64 517 10 24 16
2023/2024272 37 11 17 34 114 54 0 4 1 0 0 0
Totale 2.972